We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 36

Moneytree report shows increased life sciences investments in Q1 2011

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 19 2011

According to a PricewaterhouseCoopers report on venture capital investments, although fewer deals occurred in the first quarter of 2011 (Q1 2011) as compared to the last quarter of 2010, investment activity increased 5 percent overall

Royalty financing gains favor for VC biotech funding

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 29 2013

According to a former venture capitalist (VC), a recent deal involving a royalty in exchange for a cash infusion to develop and commercialize a

MEI Pharma secures $27.5 million in commitments to develop cancer therapy

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 15 2012

According to a news source, San Diego-based oncology company MEI Pharma, Inc. is set to raise $27.5 million from commitments to purchase its stock and warrants in a private placement

Medicinova and Zhejiang Medicine announce joint venture in China

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China

Court upholds drug profit sharing; pharma co. breached agreement to negotiate deal

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

A Delaware court has issued a letter opinion finalizing its 2011 ruling requiring SIGA Technologies Inc. to share profits from its smallpox drug with PharmAthene, Inc. PharmAthene, Inc. v. SIGA Techs, Inc., No. 267-VCP (Del. Ch., decided May 31, 2012

Venture capitalists are returning to life-sciences investing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 3 2012

Reuters reports that a number of global venture firms have renewed their interest in the life sciences and health-care sectors, motivated by big acquisitions, U.S. laws speeding up certain drug approval processes and new products that have broadened the life-sciences definition

Quebec establishes new venture capital fund to invest in biotech research

  • Shook Hardy & Bacon LLP
  • -
  • Canada
  • -
  • February 24 2011

Quebec's Charest administration has reportedly launched the third of three new venture capital funds to provide more than $41 million for investment in biotechnology research

Synageva announces $25 million for rare disease product development

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 7 2011

Synageva BioPharma Corp. has announced an additional $25 million in private equity financing to support therapeutic product development

Cincinnati investor closes $4.4 million fund to invest in startups

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 30 2011

Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio

Fewer small biotech companies go public

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 10 2011

Smaller biotechnology companies maneuvering through drug-development regulations are reportedly focusing their efforts on licensing products in development or selling their businesses to large pharmaceutical companies rather than pursuing an initial public offering (IPO